302 related articles for article (PubMed ID: 34518010)
1. Are dissecting cellulitis and hidradenitis suppurativa different diseases?
Federico A; Rossi A; Caro G; Magri F; Muscianese M; Di Fraia M; Carlesimo M
Clin Dermatol; 2021; 39(3):496-499. PubMed ID: 34518010
[TBL] [Abstract][Full Text] [Related]
2. An Up-to-Date Approach to the Management of Dissecting Cellulitis.
Nussbaum D; Desai S; Nelson K; Saardi K; Friedman A
J Drugs Dermatol; 2022 Jul; 21(7):800-802. PubMed ID: 35816064
[TBL] [Abstract][Full Text] [Related]
3. An atlas of the morphological manifestations of hidradenitis suppurativa.
Scheinfeld N
Dermatol Online J; 2014 Apr; 20(4):22373. PubMed ID: 24746309
[TBL] [Abstract][Full Text] [Related]
4. Dissecting cellulitis (Perifolliculitis Capitis Abscedens et Suffodiens): a comprehensive review focusing on new treatments and findings of the last decade with commentary comparing the therapies and causes of dissecting cellulitis to hidradenitis suppurativa.
Scheinfeld N
Dermatol Online J; 2014 May; 20(5):22692. PubMed ID: 24852785
[TBL] [Abstract][Full Text] [Related]
5. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
6. A case of dissecting cellulitis and a review of the literature.
Scheinfeld NS
Dermatol Online J; 2003 Feb; 9(1):8. PubMed ID: 12639466
[TBL] [Abstract][Full Text] [Related]
7. Hidradenitis suppurativa and follicular occlusion syndrome: Where is the pathogenetic link?
Jastrząb B; Szepietowski JC; Matusiak Ł
Clin Dermatol; 2023; 41(5):576-583. PubMed ID: 37690621
[TBL] [Abstract][Full Text] [Related]
8. The importance of histopathologic aspects in the diagnosis of dissecting cellulitis of the scalp.
Brănişteanu DE; Molodoi A; Ciobanu D; Bădescu A; Stoica LE; Brănişteanu D; Tolea I
Rom J Morphol Embryol; 2009; 50(4):719-24. PubMed ID: 19942972
[TBL] [Abstract][Full Text] [Related]
9. Follicular occlusion tetrad.
Vasanth V; Chandrashekar BS
Indian Dermatol Online J; 2014 Oct; 5(4):491-3. PubMed ID: 25396138
[TBL] [Abstract][Full Text] [Related]
10. Should hidradenitis suppurativa/acne inversa best be renamed as "dissecting terminal hair folliculitis"?
Chen W; Plewig G
Exp Dermatol; 2017 Jun; 26(6):544-547. PubMed ID: 27622389
[TBL] [Abstract][Full Text] [Related]
11. Successful use of brachytherapy for a severe hidradenitis suppurativa variant.
Paul S; Bach D; LeBoeuf NR; Devlin PM; Lipworth AD
Dermatol Ther; 2016 Nov; 29(6):455-458. PubMed ID: 27425163
[TBL] [Abstract][Full Text] [Related]
12. Dissecting cellulitis of the scalp associated with peripheral and axial spondyloarthritis: report of a case and review of the literature.
Zagelbaum Ward NK; Jun JA; Vecerek N; Donaldson M; Quismorio FP
Clin Rheumatol; 2022 Aug; 41(8):2553-2560. PubMed ID: 35460009
[TBL] [Abstract][Full Text] [Related]
13. A case of pyoderma vegetans and the follicular occlusion triad.
Boyd AS; Zemtsov A
J Dermatol; 1992 Jan; 19(1):61-3. PubMed ID: 1534334
[TBL] [Abstract][Full Text] [Related]
14. Perifolliculitis capitis abscedens et suffodiens successfully controlled with topical isotretinoin.
Karpouzis A; Giatromanolaki A; Sivridis E; Kouskoukis C
Eur J Dermatol; 2003; 13(2):192-5. PubMed ID: 12695138
[TBL] [Abstract][Full Text] [Related]
15. Refractory Dissecting Cellulitis of the Scalp Treated With Risankizumab.
Babalola F; Chima M; Jobarteh R; Gottlieb A
J Drugs Dermatol; 2022 Mar; 21(3):313-314. PubMed ID: 35254754
[TBL] [Abstract][Full Text] [Related]
16. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
Scheinfeld N
Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
[TBL] [Abstract][Full Text] [Related]
17. Follicular occlusion triad: an isotopic response or adverse effect of rituximab?
Au J; Gibson FT; Aronson IK
Dermatol Online J; 2020 Feb; 26(2):. PubMed ID: 32239887
[TBL] [Abstract][Full Text] [Related]
18. Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors: A case report and review of published cases.
Takahashi T; Yamasaki K; Terui H; Omori R; Tsuchiyama K; Fujimura T; Aiba S
J Dermatol; 2019 Sep; 46(9):802-807. PubMed ID: 31271451
[TBL] [Abstract][Full Text] [Related]
19. Perifolliculitis capitis abscedens et suffodiens in a caucasian: diagnostic and therapeutic challenge.
Mihić LL; Tomas D; Situm M; Krolo I; Sebetić K; Sjerobabski-Masnec I; Barišić F
Acta Dermatovenerol Croat; 2011; 19(2):98-102. PubMed ID: 21703156
[TBL] [Abstract][Full Text] [Related]
20. Follicular occlusion tetrad in a male patient with pachyonychia congenita: clinical and genetic analysis.
Musumeci ML; Fiorentini F; Bianchi L; Cascella R; Giardina E; Caputo V; Micali G
J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():36-39. PubMed ID: 31535756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
